Citation Impact

Citing Papers

Comprehensive Mapping of Long-Range Interactions Reveals Folding Principles of the Human Genome
2009 StandoutScience
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47
2003 StandoutScience
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Cancer immunoediting: from immunosurveillance to tumor escape
2002 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
The Inducibly Expressed GTPase Localizes to the Endoplasmic Reticulum, Independently of GTP Binding
1997
Cancer risk in patients with inflammatory bowel disease
2001 Standout
Photodynamic Therapy
1998 Standout
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
The history, properties, and biological effects of cachectin
1988 StandoutNobel
Cladribine (2-chlorodeoxyadenosine)
1992
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
2008 Standout
Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia—retrospective study and review of literature
2004
Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience
1998
The Molecular Genetics of Philadelphia Chromosome–Positive Leukemias
1988
Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer
1996 Standout
Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery
2021 StandoutNobel
Delivery technologies for cancer immunotherapy
2019 Standout
Chronic myelogenous leukemia: A review
1996
Effects of Interferon-α on Peripheral Neutrophil Counts and Serum Granulocyte Colony-Stimulating Factor Levels in Chronic Hepatitis C Patients
2000
In vivo antitumor activity of herbimycin A, a tyrosine kinase inhibitor, targeted against BCR/ABL oncoprotein in mice bearing BCR/ABL-transfected cells
1994
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
1999
Detection of minimal residual disease
2001
B-lymphoid/myeloid stem cell origin in Ph-positive acute leukemia with myeloid markers
1993
Intraperitoneal Interferon-α in Residual Ovarian Carcinoma: A Phase II Gynecologic Oncology Group Study
1999
How were new medicines discovered?
2011 Standout
Designing hydrogels for controlled drug delivery
2016 Standout
The Common Mediator of Shock, Cachexia, and Tumor Necrosis
1988 StandoutNobel
Virus-induced autoantibody response to a transgenic viral antigen
1990 StandoutNatureNobel
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
1997 Standout
In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor
2000 StandoutNobel
Cancer as an evolutionary and ecological process
2006 Standout
Tyrosine protein kinase inhibition and cancer
1994
Protein therapeutics: a summary and pharmacological classification
2007 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Complete karyotype characterization of the K562 cell line by combined application of G-banding, multiplex-fluorescence in situ hybridization, fluorescence in situ hybridization, and comparative genomic hybridization
2001
Anemia of Chronic Disease
2005 Standout
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
Interferon-γ: an overview of signals, mechanisms and functions
2003 Standout
Identification and characterization of a brain-specific antigen enriched in neonatal brain. II. Antigenic stability, species cross-reactivity and tumor cell association
1980
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]
1995 Standout
Constitutive activity of the tumor necrosis factor promoter is canceled by the 3' untranslated region in nonmacrophage cell lines; a trans-dominant factor overcomes this suppressive effect.
1992 StandoutNobel
Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavity
1986
T-cell immunity to the joining region of p210BCR-ABL protein.
1992
Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.
1988 StandoutNobel
Induction of Chronic Myelogenous Leukemia in Mice by the P210 bcr/abl Gene of the Philadelphia Chromosome
1990 StandoutScienceNobel
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Functional Role of Type I and Type II Interferons in Antiviral Defense
1994 StandoutScience
Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas
1978
Isolation and functional characterization of human intestinal mucosal lymphoid cells.
1977
Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.
1985
Preparation of Porous Polysaccharides Templated by Coordination Polymer with Three-Dimensional Nanochannels
2017 StandoutNobel
Graft-versus-leukemia reactions after bone marrow transplantation
1990 Standout
Philadelphia ChromosomePositive Leukemias: From Basic Mechanisms to Molecular Therapeutics
2003
Biochemical Pathways of Caspase Activation During Apoptosis
1999 Standout
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Cachectin: More Than a Tumor Necrosis Factor
1987 StandoutNobel
Effect of recombinant human erythropoietin combined with granulocyte/ macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome
2000
Lack of Interferon Consensus Sequence Binding Protein (ICSBP) Transcripts in Human Myeloid Leukemias
1998
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Effect of herbimycin A, an antagonist of tyrosine kinase, on bcr/abl oncoprotein-associated cell proliferations: abrogative effect on the transformation of murine hematopoietic cells by transfection of a retroviral vector expressing oncoprotein P210bcr/abl and preferential inhibition on Ph1-positive leukemia cell growth
1992
Ionizable lipid nanoparticles for in utero mRNA delivery
2021 StandoutNobel
Cytosolic expression, solution structures, and molecular dynamics simulation of genetically encodable disulfide‐rich de novo designed peptides
2018 StandoutNobel
The Two Faces of Interferon-γ in Cancer
2011
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
2003 Standout
Immune interferon and leukocyte-conditioned medium induce normal and leukemic myeloid cells to differentiate along the monocytic pathway.
1983
Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays
1998 Standout
Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals
1995
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Cytokine therapeutics: lessons from interferonalpha.
1994
The occurrence of cancer in immune deficiencies
1982
Macrophages Expressing Triggering Receptor Expressed on Myeloid Cells-1 Are Underrepresented in the Human Intestine
2005 Standout
The Biology and Detection of Immune Complexes
1980
Secretory products of macrophages.
1987 Standout
Sexual Differentiation of the Central Nervous System
1981 StandoutScience
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Interferon in Oncological Practice: Review of Interferon Biology, Clinical Applications, and Toxicities
2001

Works of Gutterman Ju being referenced

Primary brain tumors: tumor immunity and immunocompetence.
1973
Immune reactivity of lymphoid tissues adjacent to carcinoma of the ascending colon.
1974
Leukocyte interferon (IFN alpha) in patients with epithelial ovarian carcinoma.
1983
Cancer and host defense mechanisms.
1975
Human leukocyte interferon preparation-mediated block of granulopoietic differentiation in vitro.
1981
Expression of c-abl in Philadelphia-positive acute myelogenous leukemia
1987
Therapy of chronic myelogenous leukemia with recombinant interferon- gamma
1987
Minimal residual disease in interferon-treated chronic myelogenous leukemia: results and pitfalls of analysis based on polymerase chain reaction.
1992
Detection of immune complex-like materials in cancer patients' sera: a comparative study of results obtained with the C1q deviation and C1q binding tests.
1978
Treatment of hairy cell leukemia with recombinant alpha-interferon
1986
Regulation of endogenous erythropoietin levels in anemia associated with myelodysplastic syndromes [letter]
1990
Identification of molecular variants of p210bcr-abl in chronic myelogenous leukemia
1987
Treatment of hairy cell leukemia with recombinant alpha-interferon
1986
Rankless by CCL
2026